Lepski, G.; Bergami-Santos, P.C.; Pinho, M.P.; Chauca-Torres, N.E.; Evangelista, G.C.M.; Teixeira, S.F.; Flatow, E.; de Oliveira, J.V.; Fogolin, C.; Peres, N.;
et al. Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial. Cancers 2023, 15, 1239.
https://doi.org/10.3390/cancers15041239
AMA Style
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, de Oliveira JV, Fogolin C, Peres N,
et al. Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial. Cancers. 2023; 15(4):1239.
https://doi.org/10.3390/cancers15041239
Chicago/Turabian Style
Lepski, Guilherme, Patricia C. Bergami-Santos, Mariana P. Pinho, Nadia E. Chauca-Torres, Gabriela C. M. Evangelista, Sarah F. Teixeira, Elizabeth Flatow, Jaqueline V. de Oliveira, Carla Fogolin, Nataly Peres,
and et al. 2023. "Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial" Cancers 15, no. 4: 1239.
https://doi.org/10.3390/cancers15041239
APA Style
Lepski, G., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., Flatow, E., de Oliveira, J. V., Fogolin, C., Peres, N., Arévalo, A., Alves, V. A. F., & Barbuto, J. A. M.
(2023). Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial. Cancers, 15(4), 1239.
https://doi.org/10.3390/cancers15041239
